Quick Answer
ProMIS Neurosciences Inc. reported Operating Income of -$40.17 million for fiscal year 2025.
ProMIS Neurosciences Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$40.17M | -138.7% |
| 2024 | -$16.83M | -18.0% |
| 2023 | -$14.26M | +39.0% |
| 2022 | -$23.38M | -182.0% |
| 2021 | -$8.29M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$11.75M | -165.0% | -15.4% |
| June 30, 2025 | -$10.18M | -275.3% | -36.5% |
| March 31, 2025 | -$7.46M | -102.9% | -68.2% |
| September 30, 2024 | -$4.43M | -76.2% | -63.4% |
| June 30, 2024 | -$2.71M | +6.4% | +26.2% |
| March 31, 2024 | -$3.68M | +26.0% | -46.0% |
| September 30, 2023 | -$2.52M | +58.4% | +13.2% |
| June 30, 2023 | -$2.90M | +40.4% | +41.7% |
- ProMIS Neurosciences Inc. showed a decrease of -138.7% in Operating Income compared to the prior fiscal year.
- Over the 2021–2025 period, ProMIS Neurosciences Inc.’s operating income has declined by 384.5% (from -$8.29 million to -$40.17 million).
- The most recent figure is from ProMIS Neurosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: